A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Author:                            

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.29, Iss.5, 2013-01, pp. : 2011-2018

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content